Announced Thu, 1 Oct, 2026 · 20:10 IST
Bayer distribution arrangement to end on 31 Dec 2026, no renewal
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹198.30
prior close
₹197.97
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.1-0.1-0.3+1.3+2.5-1.2———————
Up moveDown movePending
AI summary
Piramal Pharma's sales and distribution support arrangement with Bayer Pharmaceuticals will expire on 31 December 2026 and will not be renewed. The company earned a commission for these services. Revenue from this deal accounts for less than 5 percent of consolidated revenue. As the arrangement is commission-based, Piramal does not expect the non-renewal to materially impact profitability or financial position. The company is coordinating a smooth handover of these activities with Bayer.
Likely market impact
Minimal financial impact as deal is under 5 percent of revenue and commission-based. No material effect on profitability expected.